Michael Scordo, in New York, NY - Medicare Hematology/oncology

Michael Scordo, is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in New York, New York. He graduated from medical school in 2011 and has 13 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Memorial Hematology Lymphoma Group, Mskcc Clinical Practice Plan and his current practice location is 1275 York Ave, New York, New York. You can reach out to his office (for appointments etc.) via phone at (212) 639-2000.

Michael Scordo is licensed to practice in New York (license number 273619) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003115700.

Contact Information

	Michael Scordo,
	1275 York Ave, New York, NY 10065-6007
	(212) 639-2000
	Not Available

Physician's Profile

Full Name	Michael Scordo
Gender	Male
Speciality	Hematology/oncology
Experience	13 Years
Location	1275 York Ave, New York, New York
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Michael Scordo graduated from medical school in 2011

NPI Data:

NPI Number: 1003115700
Provider Enumeration Date: 03/21/2011
Last Update Date: 02/25/2019

Medicare PECOS Information:

PECOS PAC ID: 7012282973
Enrollment ID: I20171004000134

Medical Identifiers

Medical identifiers for Michael Scordo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003115700	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	273619 (New York)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Memorial Hematology Lymphoma Group	7113816489	175
Mskcc Clinical Practice Plan	4981704541	76

News Archive

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

Cytomedix, Inc. today announced that the Company has been issued a CE marking certification for its Angel® Whole Blood Separation System ("Angel") and its activAT® Autologous Thrombin Processing Kit ("activAT").

NanoString Technologies receives ISO 13485:2003 certification

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has received ISO 13485:2003 certification, an internationally recognized quality standard for medical devices.

Study finds factors contributing to drug abuse among disadvantaged, rural youth

Having grown up poor in a rural village in Zimbabwe, Wilson Majee saw firsthand as a child the lack of educational opportunities that were easily accessible and how that impacted the youth in his village.

Research shows new method for rapidly producing antimalarial drug at industrial scale

Compared to smallpox or typhoid, malaria is proving one of the most challenging human diseases to eradicate - and so remains a real and constant danger to nearly half the world's population.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michael Scordo allows following entities to bill medicare on his behalf.

Entity Name	Memorial Hematology Lymphoma Group
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1891766366 PECOS PAC ID: 7113816489 Enrollment ID: O20040313000643

News Archive

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

NanoString Technologies receives ISO 13485:2003 certification

Study finds factors contributing to drug abuse among disadvantaged, rural youth

Research shows new method for rapidly producing antimalarial drug at industrial scale

Compared to smallpox or typhoid, malaria is proving one of the most challenging human diseases to eradicate - and so remains a real and constant danger to nearly half the world's population.

Entity Name	Mskcc Clinical Practice Plan
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1588789341 PECOS PAC ID: 4981704541 Enrollment ID: O20070711000565

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

NanoString Technologies receives ISO 13485:2003 certification

Study finds factors contributing to drug abuse among disadvantaged, rural youth

Research shows new method for rapidly producing antimalarial drug at industrial scale

Compared to smallpox or typhoid, malaria is proving one of the most challenging human diseases to eradicate - and so remains a real and constant danger to nearly half the world's population.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael Scordo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael Scordo, 1275 York Ave, New York, NY 10065-6007 Ph: () -	Michael Scordo, 1275 York Ave, New York, NY 10065-6007 Ph: (212) 639-2000

News Archive

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

NanoString Technologies receives ISO 13485:2003 certification

Study finds factors contributing to drug abuse among disadvantaged, rural youth

Research shows new method for rapidly producing antimalarial drug at industrial scale

Compared to smallpox or typhoid, malaria is proving one of the most challenging human diseases to eradicate - and so remains a real and constant danger to nearly half the world's population.

Internal Medicine Doctors in New York, NY

Dr. Ravishankar Ramaswamy, MD, MS Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1440 Madison Avenue, New York, NY 10029 Phone: 212-659-8552 Fax: 212-860-9737
Dr. Pietro Alessandro Ambrogio Canetta, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, Ph4-124, New York, NY 10032 Phone: 212-305-5020 Fax: 212-305-6692
Dr. Rakhshan Mahmood Chida, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 327 E 17th St, New York, NY 10003 Phone: 212-420-5690
Charles D Resor, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, New York, NY 10032 Phone: 212-305-2913
Dr. Jacqueline Yuey Lonier, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1150 Saint Nicholas Ave, New York, NY 10032 Phone: 212-851-5494
Dr. Sharon Uralil, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-3293
Diana Kantor, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 775 9th Ave, New York, NY 10019 Phone: 212-586-1550

Michael Scordo, - Medicare Hematology/oncology in New York, NY

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

NanoString Technologies receives ISO 13485:2003 certification

Study finds factors contributing to drug abuse among disadvantaged, rural youth

Research shows new method for rapidly producing antimalarial drug at industrial scale

Medicare Reassignments

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

NanoString Technologies receives ISO 13485:2003 certification

Study finds factors contributing to drug abuse among disadvantaged, rural youth

Research shows new method for rapidly producing antimalarial drug at industrial scale

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

NanoString Technologies receives ISO 13485:2003 certification

Study finds factors contributing to drug abuse among disadvantaged, rural youth

Research shows new method for rapidly producing antimalarial drug at industrial scale

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Cytomedix granted CE mark for Angel Blood Separation System and activAT Autologous Thrombin Processing Kit

NanoString Technologies receives ISO 13485:2003 certification

Study finds factors contributing to drug abuse among disadvantaged, rural youth

Research shows new method for rapidly producing antimalarial drug at industrial scale

Internal Medicine Doctors in New York, NY